Translational Medicine: Application of Omics for Drug Target Discovery and Validation
暂无分享,去创建一个
Xuewu Zhang | Wei Wang | Lei Shi | Kaijun Xiao | Xuewu Zhang | Lei Shi | Kaijun Xiao | W. Wang
[1] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Keun,et al. Application of metabonomics in drug development. , 2007, Pharmacogenomics.
[3] A. D. De Marzo,et al. Abnormal DNA methylation, epigenetics, and prostate cancer. , 2007, Frontiers in bioscience : a journal and virtual library.
[4] M. Gladwin,et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. , 2006, Kidney international.
[5] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[6] T. Yip,et al. ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. , 2007, Clinical chemistry.
[7] Sean Ekins,et al. A novel method for generation of signature networks as biomarkers from complex high throughput data. , 2005, Toxicology letters.
[8] A. Biondi,et al. Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform , 2008, Leukemia.
[9] Xuewu Zhang,et al. Mass spectrometry-based "omics" technologies in cancer diagnostics. , 2007, Mass spectrometry reviews.
[10] Yi Guo,et al. Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel. , 2007, Cancer research.
[11] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[12] E. Yim,et al. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. , 2005, Gynecologic oncology.
[13] Jeffrey S Ross,et al. Multigene predictors in early-stage breast cancer: moving in or moving out? , 2008, Expert review of molecular diagnostics.
[14] B. Grosbois,et al. Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[16] R. Dean,et al. Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical model. , 2007, Journal of proteome research.
[17] Ben van Ommen,et al. Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. , 2003, Biochemical pharmacology.
[18] F. Jiang,et al. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach , 2006, Oncogene.
[19] P. Jannetto,et al. Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology Workstation. , 2007, Clinical chemistry.
[20] Commentary: Where and how could biomarkers be used in 2016 , 2006, The AAPS Journal.
[21] Philippe Froguel,et al. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. , 2008, Human molecular genetics.
[22] Yusuke Nakamura,et al. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. , 2002, Cancer research.
[23] R. Bast,et al. Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.
[24] R. Goodacre. Metabolomics of a superorganism. , 2007, The Journal of nutrition.
[25] M. Cronin,et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Robert P Tonge,et al. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[27] T. Yip,et al. Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling , 2004, Clinical Cancer Research.
[28] P. Brown,et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] Xuewu Zhang,et al. Biomarker validation: movement towards personalized medicine , 2007, Expert review of molecular diagnostics.
[30] J. Dear,et al. Liver proteomics for therapeutic drug discovery: Inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure* , 2007, Critical care medicine.
[31] E. Davidov,et al. Advancing drug discovery through systems biology. , 2003, Drug discovery today.
[32] Martin Widschwendter,et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. , 2005, Cancer research.
[33] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[34] S. Mathoulin-Pélissier,et al. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel. , 2006, Pharmacogenomics.
[35] Thomas P Conrads,et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] Huanwen Chen,et al. Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation. , 2006, Rapid communications in mass spectrometry : RCM.
[37] M. Tomita,et al. Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption* , 2006, Journal of Biological Chemistry.
[38] J. Griffiths,et al. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. , 2006, Cancer research.
[39] Yingdong Zhao,et al. Common cancer biomarkers. , 2006, Cancer research.
[40] John C Lindon,et al. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. , 2004, Journal of pharmaceutical and biomedical analysis.
[41] C. Huck,et al. Biomarker discovery in breast cancer serum using 2‐D differential gel electrophoresis/ MALDI‐TOF/TOF and data validation by routine clinical assays , 2006, Electrophoresis.
[42] F. Eckhardt,et al. DNA methylation markers: a versatile diagnostic tool for routine clinical use. , 2007, Current opinion in molecular therapeutics.
[43] R. Stephens,et al. A Combined Proteome and Microarray Investigation of Inorganic Phosphate-induced Pre-osteoblast Cells*S , 2005, Molecular & Cellular Proteomics.
[44] Götz Schlotterbeck,et al. Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine. , 2006, Chemical research in toxicology.
[45] Elaine Holmes,et al. Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. , 2006, Journal of proteome research.
[46] O. Fiehn. Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.
[47] Rafael A Irizarry,et al. Comprehensive high-throughput arrays for relative methylation (CHARM). , 2008, Genome research.
[48] Ruili Huang,et al. Targeting changes in cancer: assessing pathway stability by comparing pathway gene expression coherence levels in tumor and normal tissues , 2006, Molecular Cancer Therapeutics.
[49] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[50] Feng Chen,et al. Moving cancer diagnostics from bench to bedside. , 2007, Trends in biotechnology.